News

WHO Global TB Report 2013: Slow decline in Disease Burden, New Tools Needed to Reach Goals

24 Oct 2013
by Working Group
Action Events TB News TB Prevention and Control Strategies
advocacy children community crisis diagnostics epidemic funding HBCs high burden countries innovations mdr pediatric press publications stop tb stop tb partnership targets treatment WHO

Click to access report.

This is the eighteenth global report on tuberculosis (TB) published by WHO in a series that started in 1997. It provides a comprehensive and up-to-date assessment of the TB epidemic and progress in implementing and financing TB prevention, care and control at global, regional and country levels using data reported by 197 countries and territories that account for over 99% of the world’s TB cases…continue reading at http://www.who.int/tb/publications/global_report/en/.

Additional Coverage:

TB challenge over ‘missing’ millions (BBC)

Drug-Resistant TB Officially a ‘Crisis’ – Now What? (Huffington Post)

As WHO TB report shows 3 million undiagnosed and cites drug-resistance “public health crisis,” physicians urge Obama to increase funding (ScienceSpeaks)

More News
19 Mar 2024

Most Robust TB Drug Pipeline in History

For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...
3 Aug 2023

New Tools Summit in Paris this November

The Working Group on New TB Drugs, in collaboration with the New Diagnostics Working Group, Working Group on New Vaccines, FIND, IAVI, and TB Alliance, is co-hosting a New Tools Summit at the Marriot Champs Elysée Hotel in Paris, France on Tuesday, 14 November 2023. The WGND Annual Meeting will be...
23 Aug 2022

PAN-TB Collaboration Announces Novel TB Drug Regimens Trial

The PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates Foundation, the PAN-TB, or “Project to Accelerate New Treatments for Tuberculosis”, collaboration brings together non-...